![](/img/cover-not-exists.png)
346 Taxol or doxorubicin as first line chemotherapy in advanced breast cancer (ABC). A prospective randomized phase II study with crossover
R. Paridaens, P. Bruning, F. Calabresi, A. Awada, J.A. Roy, Z. Kusenda, M. PiccartVolume:
31
Year:
1995
Language:
english
Pages:
1
DOI:
10.1016/0959-8049(95)95599-2
File:
PDF, 126 KB
english, 1995